Remove 2010 Remove Conditions Remove Therapy Remove Treatment
article thumbnail

Leading Investment Fund in the Psychedelics and Mental Health Space Issues Statement on atai Life Sciences IPO Listing

Cannabis Law Report

On June 18, 2021, Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering. . trillion by 2030.

article thumbnail

GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders

Cannabis Law Report

A coalition of Pennsylvania lawmakers introduced a bill this week that’s meant to promote research into the therapeutic potential of psilocybin mushrooms for mental health conditions such as post-traumatic stress disorder (PTSD)—the latest example of how the psychedelics reform movement is gaining momentum. Led by Rep.

Therapy 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Investment Fund in the Psychedelics and Mental Health Space Issues Statement on atai Life Sciences IPO Listing

Cannabis Law Report

June 18, 2021 (Chicago) — Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences ’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering.

article thumbnail

Intro to CBG

CannaMD

An emerging body of research suggests that CBG may have therapeutic value in the treatment of conditions ranging from Crohn’s disease and IBS to certain types of cancer. CBG is known to have anti-inflammatory properties that could prove useful in the treatment of numerous inflammatory diseases. IS CBG THE NEW CBD?

article thumbnail

How Good Is Cannabis for Multiple Sclerosis (MS)?

Greencamp

According to MS Society of Canada , 1 in every 385 Canadians lives with this condition. As it’s one of the most debilitating conditions, living with multiple sclerosis is a real battle. For patients who don’t respond well to conventional MS methods, cannabis treatment seems like a very reasonable choice. three days.

article thumbnail

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Cannabis Law Report

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid (GABA) facilitator and glutamate antagonist, an effective treatment for alcoholism. Johnson received the R. Ehave, Inc.

article thumbnail

Cannabis – The study that blew my mind

Cannabis Law Report

At current, transplant treatments are hindered by our understanding of the immune response of those receiving treatments. More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-de?ciency doi: 10.1182/BLOOD-2010-12-323824. Burstein, S.